The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

V.P. Erichev

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

S.Iu. Petrov

FGBU "NII glaznykh bolezneĭ" RAMN

A.V. Volzhanin

Research Institute of Eye Diseases, 11, A, B, Rossolimo St., Moscow, Russian Federation, 119021

S.A. Ghazaryan

Yerevan State Medical University after Mkhitar Heratsi, 2 Koryuna St., Erevan, Republic of Armenia, 0025

Continuous anti-glaucoma drug therapy as a risk factor of dry eye

Authors:

V.P. Erichev, S.Iu. Petrov, A.V. Volzhanin, S.A. Ghazaryan

More about the authors

Journal: Russian Annals of Ophthalmology. 2019;135(6): 117‑123

Views: 5351

Downloaded: 137


To cite this article:

Erichev VP, Petrov SIu, Volzhanin AV, Ghazaryan SA. Continuous anti-glaucoma drug therapy as a risk factor of dry eye. Russian Annals of Ophthalmology. 2019;135(6):117‑123. (In Russ.)
https://doi.org/10.17116/oftalma2019135061117

Recommended articles:
Modern achievements in the diagnosis and treatment of glaucoma. Russian Annals of Ophthalmology. 2023;(3):96-106
Current possibilities of laser surgery on ante­rior eye segment. Russian Annals of Ophthalmology. 2023;(3):107-112
Micro-invasive glaucoma surgery. Russian Annals of Ophthalmology. 2023;(5):90-95
The asso­ciation between myopia and glaucoma. Russian Annals of Ophthalmology. 2024;(1):93-98

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.